PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: biology

IMPURITIES IN EW DRUG SUBSTANCES Q3A(R2) - ICH

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE IMPURITIES IN NEW DRUG SUBSTANCES Q3A(R2) Current Step 4 version dated 25 October 2006 This Guideline has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. At Step 4 of the Process the final draft is recommended for adoption to the regulatory bodies of the European Union, Japan and USA. Q3A(R2) Document History First Codification History Date New Codification November 2005 Q3 Approval by the Steering Committee under Step 2 and release for public consultation.

3.1 Organic Impurities The applicant should summarise the actual and potential impurities most likely to arise during the synthesis, purification, and storage of the new drug substance. This summary should be based on sound scientific appraisal of the chemical reactions

Tags:

  Summary, Reactions, Organic

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of IMPURITIES IN EW DRUG SUBSTANCES Q3A(R2) - ICH

Related search queries